BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Kyverna Therapeutics Announces New Patient Data Highlighting Potential of KYV-101 for Treatment of Lupus Nephritis in Symposium at ACR Convergence 2024

  November 14, 2024

   · 

  7 min read
• Press Releases

  Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren’s disease study

  November 14, 2024

   · 

  13 min read
• Press Releases

  Sparrow Pharmaceuticals to Present Two Abstracts at ACR Convergence 2024 and Expand Phase 2 Clinical Trial of Clofutriben with Prednisolone for Polymyalgia Rheumatica to Fifth Cohort

  November 14, 2024

   · 

  2 min read
• Press Releases

  Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

  November 14, 2024

   · 

  12 min read
• Press Releases

  FDA Grants De Novo Authorization to OMRON Healthcare for New Blood Pressure Monitors with AI-Powered AFib Detection Feature

  November 14, 2024

   · 

  5 min read
• Press Releases

  Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development

  November 14, 2024

   · 

  3 min read
• Press Releases

  New Development in Rare Pediatric Epilepsy: Biocodex Announces the Development of DIACOMIT® (stiripentol) Oral Suspension, a New Formulation to Aid in the Treatment of Dravet Syndrome in Young Children

  November 14, 2024

   · 

  6 min read
• Press Releases

  In Vitro Diagnostics (IVD) Market Size to Surpass USD 157.56 Billion by 2034

  November 14, 2024

   · 

  1 min read
• Press Releases

  ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital

  ◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.

  November 14, 2024

   · 

  1 min read
• Press Releases

  New BIMZELX® (bimekizumab-bkzx) Data at ACR Convergence 2024 Highlights UCB’s Efforts to Deliver Differentiated Care for Patients with Psoriatic Arthritis and Axial Spondyloarthritis

  November 14, 2024

   · 

  24 min read